Literature DB >> 17612614

Sequence and transcriptional study of HNRPK pseudogenes, and expression and molecular modeling analysis of hnRNP K isoforms.

Andréia M Leopoldino1, Fernanda Carregaro, Carlos H T P Silva, Olavo Feitosa, Ulises M Mancini, Jorge M Freitas, Eloiza H Tajara.   

Abstract

The heterogeneous nuclear ribonucleoproteins (hnRNPs) comprise a large family of proteins that play important roles in telomere biogenesis, DNA repair, cellular signaling, and the regulation of expression at both the transcriptional and translational levels. One of the most extensively studied hnRNP family members, hnRNP K, has been implicated in a variety of processes, including chromatin remodeling, transcription, splicing, and translation events. In this study, we analyzed processed HNRPK pseudogenes (HNRPK psi1-psi4) and coding sequences. HNRPK pseudogenes are apparently nonfunctional, and psi1 might correspond to transcripts from an ancestral gene. Phylogenetic and sequence analyses suggest that HNRP genes arose by duplication, and that new structural and sequence features expanded the functions of hnRNPs. The expression analysis of hnRNP K isoforms showed that isoform a is expressed in normal testis and in non-small cell lung cancer (NCI-H1155 NSCLC cell line), although the shorter isoform (isoform b) is expressed in different tumor cell lines (IM9 B-lymphoblastoid, Hs578T human breast cancer epithelial, T98G human glioma cell lines). Using molecular modeling, we obtained KH1 and KH3 models, which pointed to important residues for DNA-protein binding and no structural differences between isoforms a and b. To our knowledge, this is the first phylogenetic study including vertebrate HNRP genes and HNRPK pseudogenes, and the first report comparing the KH1 and KH3 domains of isoforms a and b of the hnRNP K protein. New investigations in tumor samples must be done to validate the differential expression observed here. The results shown are important because the hnRNP K protein might represent a new target for pharmacologic intervention in virus replication and cancer.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17612614     DOI: 10.1139/g07-016

Source DB:  PubMed          Journal:  Genome        ISSN: 0831-2796            Impact factor:   2.166


  6 in total

1.  Heterogeneous nuclear ribonucleoprotein K inhibits heat shock-induced transcriptional activity of heat shock factor 1.

Authors:  Hee-Jung Kim; Jae-Jin Lee; Jin-Hwan Cho; Jaeho Jeong; A Young Park; Wonmo Kang; Kong-Joo Lee
Journal:  J Biol Chem       Date:  2017-06-07       Impact factor: 5.157

Review 2.  Expression of evolutionarily novel genes in tumors.

Authors:  A P Kozlov
Journal:  Infect Agent Cancer       Date:  2016-07-19       Impact factor: 2.965

3.  Identification of Prognostic Alternative Splicing Signature in Breast Carcinoma.

Authors:  Dong Zhang; Yi Duan; Jinjing Cun; Qifeng Yang
Journal:  Front Genet       Date:  2019-03-28       Impact factor: 4.599

Review 4.  Post-translational modification control of RNA-binding protein hnRNPK function.

Authors:  Yongjie Xu; Wei Wu; Qiu Han; Yaling Wang; Cencen Li; Pengpeng Zhang; Haixia Xu
Journal:  Open Biol       Date:  2019-03-29       Impact factor: 6.411

5.  Up-regulation of exosomal miR-125a in pneumoconiosis inhibits lung cancer development by suppressing expressions of EZH2 and hnRNPK.

Authors:  Lin Zhang; Jiangfeng Li; Changfu Hao; Wei Guo; Di Wang; Jianhui Zhang; Youliang Zhao; Shuyin Duan; Wu Yao
Journal:  RSC Adv       Date:  2018-07-25       Impact factor: 4.036

6.  Crosstalk between hnRNP K and SET in ATRA-induced differentiation in acute promyelocytic leukemia.

Authors:  Karina Stringhetta Padovani; Renata Nishida Goto; Lais Brigliadori Fugio; Cristiana Bernadelli Garcia; Vani Maria Alves; Maria Sol Brassesco; Lewis Joel Greene; Eduardo Magalhães Rego; Andréia Machado Leopoldino
Journal:  FEBS Open Bio       Date:  2021-06-17       Impact factor: 2.693

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.